Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos

Return to: PBR Home | Packaging


Catalent completes acquisition of Australia's Pharmapak By PBR Staff Writer
US-based Catalent Pharma Solutions has strengthened its ability to provide integrated solutions to customers with the acquisition of Pharmapak Technologies, an Australian pharmaceutical packaging business.
Packaging > News
MP Global Products introduces foam-free packaging for shipment of temperature sensitive pharmaceuticals MP Global Thermal Packaging Products insulated protective mailers and box liners are specifically designed for temperature control and protection of mail order shipments of temperature sensitive pharma, pet meds, and natural and organic cosmetics.
Packaging > News Bosch expands CPS portfolio for serialization of pharmaceutical packaging Bosch Packaging Technology, a leading supplier of process and packaging technology, has expanded its portfolio for the serialization of pharmaceutical packaging. In the fight against counterfeit drugs, many countries are about to implement legislation changes for a stricter labelling of pharmaceuticals. Consequently, drug manufacturers require safer and more flexible solutions.
Packaging > News
See more Packaging news

Latest Packaging News and Insight

View all Packaging news or find news targeted to your interests
Rentschler - High-Performance Biopharmaceutical Development and Manufacturing
Identifying the most appropriate contract manufacturer who can best fulfil what you need for your lead pharmaceutical candidate is a real challenge. With over 40 years’ experience, Rentschler is one of the industry leaders for contract development and manufacturing.
Packaging > Suppliers
Rentschler Expands Single-Use Manufacturing Capacities
2,000 L single-use bioreactor is planned to be in operation by the beginning of 2015.
Packaging > Press Releases
Rentschler Invests EUR 24 Million in Stainless Steel Bioreactor Manufacturing
Rentschler announces the building of a Twin system with two 3,000 Liter stainless steel bioreactors mainly targeting market supply
Packaging > Press Releases
Single-Use-Bioprocesses – Hype or Future Technology?
| By Rentschler
Single-use bioreactors offer many advantages for the manufacturing of biopharmaceuticals. They are used in approximately two thirds of all new bioprocesses in the biopharmaceutical market and have become indispensable in biopharmaceutical development and production processes.
Packaging > White Papers
Cell Line Development
Rentschler provides comprehensive development expertise covering all stages of drug development in mammalian cell culture.
Packaging > Products
Bioprocess and Formulation Development
Rentschler delivers upstream process (USP) development for cell cultivation and downstream process (DSP) development for protein purification as well as formulation development.
Packaging > Products
Mammalian Cell Culture Manufacturing
In our cGMP certified facilities we manufacture biopharmaceuticals for clinical studies and commercial supplies. Multi-product facilities with stainless steel bioreactors lines up to 3,000 L and single-use bioreactors up to 2,000 L allow a high degree of flexibility.
Packaging > Products
Aseptic Filling
Our experience with a broad range of substance classes allows individual solutions for challenging substances.
Packaging > Products
View all Packaging news or find news targeted to your interests